 SOUTH SAN FRANCISCO, Calif., March 08, 2022 GLOBE NEWSWIRE -- Nkarta, Inc. Nasdaq: NKTX, a biopharmaceutical company developing engineered natural killer NK cell therapies to treat cancer, today announced that it will present four posters at the upcoming American Association for Cancer Research AACR Annual Meeting to be held April 8 to 13, 2022. 